Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. - Tamura R; Fujioka M; Morimoto Y; Ohara K; Kosugi K; Oishi Y; Sato M; Ueda R; Fujiwara H; Hikichi T; Noji S; Oishi N; et al. (Nature communications, 2020)